Venker Eric's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Dec 29, 2025
- Accession no.
- 0001140361-25-046786
- Filed
- Dec 29, 2025
- Trade date
- Dec 23-24, 2025
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.18M. It was filed 6 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Venker EricCIK 0001801917 | Officer (President & Immunovant CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Common Shares | MOption exerciseAcquired | +313,841 | $3.85 | +$1,208,287.85 | 1,811,749 | Direct | |
| Dec 23, 2025 | Common Shares | SSaleDisposed | −200,000 | $22.45 | −$4,490,000 | 1,611,749 | Direct | |
| Dec 24, 2025 | Common Shares | MOption exerciseAcquired | +117,848 | $3.85 | +$453,714.8 | 1,729,597 | Direct | |
| Dec 24, 2025 | Common Shares | SSaleDisposed | −75,000 | $22.53 | −$1,689,750 | 1,654,597 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Common Stock | MOption exerciseDisposed | −313,841 | $0.00 | $0 | 5,562,682 | Direct | |
| Dec 24, 2025 | Common Stock | MOption exerciseDisposed | −117,848 | $0.00 | $0 | 5,444,834 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.